144 related articles for article (PubMed ID: 12845654)
1. Incidence and survival of Swedish patients with differentiated thyroid cancer.
Lundgren CI; Hall P; Ekbom A; Frisell J; Zedenius J; Dickman PW
Int J Cancer; 2003 Sep; 106(4):569-573. PubMed ID: 12845654
[TBL] [Abstract][Full Text] [Related]
2. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
[TBL] [Abstract][Full Text] [Related]
3. Differences in the Impact of Age on Mortality in Well-Differentiated Thyroid Cancer.
Yan H; Winchester DJ; Prinz RA; Wang CH; Nakazato Y; Moo-Young TA
Ann Surg Oncol; 2018 Oct; 25(11):3193-3199. PubMed ID: 30039325
[TBL] [Abstract][Full Text] [Related]
4. Differentiated thyroid carcinoma: comparison between papillary and follicular carcinoma in a single institute.
Chow SM; Law SC; Au SK; Leung TW; Chan PT; Mendenhall WM; Lau WH
Head Neck; 2002 Jul; 24(7):670-7. PubMed ID: 12112541
[TBL] [Abstract][Full Text] [Related]
5. Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China.
Du L; Wang Y; Sun X; Li H; Geng X; Ge M; Zhu Y
BMC Cancer; 2018 Mar; 18(1):291. PubMed ID: 29544469
[TBL] [Abstract][Full Text] [Related]
6. Significance of tumor capsular invasion in well-differentiated thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
Am Surg; 2007 May; 73(5):484-91. PubMed ID: 17521005
[TBL] [Abstract][Full Text] [Related]
7. Comparison of survival rates between papillary and follicular thyroid carcinomas among 36,725 patients.
Oyer SL; Fritsch VA; Lentsch EJ
Ann Otol Rhinol Laryngol; 2014 Feb; 123(2):94-100. PubMed ID: 24574464
[TBL] [Abstract][Full Text] [Related]
8. Factors related to mortality in patients with papillary and follicular thyroid cancer in long-term follow-up.
de Melo TG; Zantut-Wittmann DE; Ficher E; da Assumpção LV
J Endocrinol Invest; 2014 Dec; 37(12):1195-200. PubMed ID: 25037473
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region.
Passler C; Scheuba C; Prager G; Kaczirek K; Kaserer K; Zettinig G; Niederle B
Endocr Relat Cancer; 2004 Mar; 11(1):131-9. PubMed ID: 15027890
[TBL] [Abstract][Full Text] [Related]
10. Spinal metastases due to thyroid carcinoma: an analysis of 202 patients.
Kushchayeva YS; Kushchayev SV; Carroll NM; Felger EA; Links TP; Teytelboym OM; Bonichon F; Preul MC; Sonntag VK; Van Nostrand D; Burman KD; Boyle LM
Thyroid; 2014 Oct; 24(10):1488-500. PubMed ID: 24921429
[TBL] [Abstract][Full Text] [Related]
11. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
Lundgren CI; Hall P; Dickman PW; Zedenius J
Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
[TBL] [Abstract][Full Text] [Related]
12. Follicular variant papillary thyroid carcinoma in a pediatric population.
Lerner J; Goldfarb M
Pediatr Blood Cancer; 2015 Nov; 62(11):1942-6. PubMed ID: 26131690
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of a rare subtype of thyroid cancer: Spindle cell thyroid carcinoma.
Liu Z; Zhao Q; Zeng W; Wang S; Xiong Y; Guo H; Huang T; Cheng H; Guo L
Medicine (Baltimore); 2018 Nov; 97(45):e13053. PubMed ID: 30407303
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
Yang Z; Flores J; Katz S; Nathan CA; Mehta V
Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
[TBL] [Abstract][Full Text] [Related]
15. Incidence and Survival in Reproductive-Aged Women with Differentiated Thyroid Cancer: United States SEER 18 2000-2016.
Douglas EH; Rhoads A; Thomas A; Aloi J; Suhl J; Lycan T; Oleson J; Conway KM; Klubo-Gwiezdzinska J; Lynch CF; Romitti PA
Thyroid; 2020 Dec; 30(12):1781-1791. PubMed ID: 32394796
[No Abstract] [Full Text] [Related]
16. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
17. Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases.
Yu XM; Schneider DF; Leverson G; Chen H; Sippel RS
Thyroid; 2013 Oct; 23(10):1263-8. PubMed ID: 23477346
[TBL] [Abstract][Full Text] [Related]
18. NONOPERATIVE MANAGEMENT OF DIFFERENTIATED THYROID CANCER IN CALIFORNIA: A POPULATION-LEVEL ANALYSIS OF 29,978 PATIENTS.
Kuo EJ; Wu JX; Li N; Zanocco KA; Yeh MW; Livhits MJ
Endocr Pract; 2017 Oct; 23(10):1262-1269. PubMed ID: 28816539
[TBL] [Abstract][Full Text] [Related]
19. High recurrent rate of multicentric papillary thyroid carcinoma.
Lin JD; Chao TC; Hsueh C; Kuo SF
Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
[TBL] [Abstract][Full Text] [Related]
20. Disease-free survival in papillary and follicular thyroid carcinoma. Comparison between UICC 5th and 7th classifications of T stage, and the prognostic value of primary tumour size.
Meixner M; Hellmich M; Dietlein M; Kobe C; Schicha H; Schmidt M
Nuklearmedizin; 2013; 52(3):71-80. PubMed ID: 23483137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]